2021, Number 03
Influence of physical therapy in the functional capacity of patients with ischemic cardiopathy
Language: Spanish
References: 19
Page:
PDF size: 1471.80 Kb.
ABSTRACT
Introduction: Patients with a history of ischemic cardiopathy generally don´t want to abandon a physical or sport activity; on the other side, they can undoubtedly obtain benefits from a physical exercise plan which brings a better life quality.Objective: To evaluate he functional capacity of patients with ischemic cardiopathy who have been rehabilitated with physical therapy, according to the ergometric trace.
Method: A descriptive, longitudinal and prospective study was carried out in the Physical Therapy and Rehabilitation Service from Dr. Juan Bruno Zayas Teaching in Santiago de Cuba during the biennium 2007-2019, in 41 patients who had suffered from a myocardial infarction and were included in a cardiovascular rehabilitation program. To determine the functional capacity, the cardiovascular risk level was compared to the functional class before and after the physical exercise.
Results: It was achieved to modify the ergometric response in 87.8 % after applying the rehabilitation program, while the cardiovascular state according to the risk level of the patients was modified in 68.2 % towards the low risk and the functional capacity showed an improvement of 82.9%.
Conclusions: The implementation of a cardiac rehabilitation program was useful in most of the patients, and a significant improvement of the evaluated cardiovascular parameters was obtained, what pointed at a reestablishment of the life quality and of tolerance to efforts.
REFERENCES
Matuleviciene-Anangen V, Rosengren A, Svensson AM, Pivodic A, Gudbjornsdottir S, Wedel H, et al. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes. Heart. 2017 [citado 13/04/2020];103(21):1687-95. Disponible en: https://heart.bmj.com/lookup/pmidlookup?view=long&pmid=28710186
Thanassoulis G, Williams K, Altobelli KK, Pencina MJ, Cannon CP, Sniderman AD. Individualized statin benefit for determining statin eligibility in the primary prevention of cardiovascular disease. Circulation. 2016 [citado 13/04/2020];133(16):1574-81. Disponible en: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.115.018383?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016 [citado 13/04/2020];37(29):2315-81. Disponible en: https://watermark.silverchair.com/ehw106.pdf
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 [citado 13/04/2020];71:13-115. Disponible en: https://www.ahajournals.org/doi/epub/10.1161/HYP.0000000000000065
Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC, Rahimi K, Yusuf S, et al. Blood pressure lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data. PLoS Med. 2018 [citado 13/04/2020];15(3):e1002538. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860698/